July 31, 2023 Comments Off on New tentative approval for Optimus Pharma drug obeticholic acid Posted in: Tentative Approval Obeticholic acid is the generic ingredient in one branded drug marketed by Intercept Pharms Inc and is included in one NDA. There are ten patents protecting this compound. Drug patent…
The post New tentative approval for Optimus Pharma drug obeticholic…
July 31, 2023 Comments Off on New patent expiration for Astrazeneca Ab drug ONGLYZA Posted in: Uncategorized
Annual Drug Patent Expirations for ONGLYZA Onglyza is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from two suppliers. There are two patents…
The post New patent expiration for Astrazeneca Ab drug ONGLYZA appeared first…
